Nonventilator hospital-acquired pneumonia (NV-HAP) is one of the most prevalent and deadly hospital-acquired infections (HAI) and significantly affects patient outcomes. Findings from a 2023 study conducted in 284 US hospitals revealed that NV-HAP contributed to 1 in 14 hospital deaths, posing an inpatient mortality rate of 22.4%. Furthermore, NV-HAP was linked to substantial morbidity and…
Hospital-acquired pneumonia stands among the most prevalent and fatal patient complications encountered during hospital stays. Despite advances in decreasing ventilator-associated pneumonia rates, non-ventilator hospital-acquired pneumonia (NVHAP) remains a silent, yet potent, adversary often overlooked in patient safety strategies. A distinction worth noting is that NVHAP develops in non-ventilated hospital patients, unlike its counterpart, ventilator-associated pneumonia.…
Hospital-acquired pneumonia (HAP) represents a significant challenge within the healthcare field on multiple levels, not least owing to its tendency to lead to high rates of patient mortality, increased healthcare costs, and extensive usage of intensive care units (ICUs). However, one often overlooked yet substantially effective preventive measure is regular oral hygiene.
HAP, an infection primarily…